Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03628677
Title A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Arcus Biosciences, Inc.
Age Groups: senior | adult
Covered Countries USA | AUS

No variant requirements are available.